Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | NT5E | P21589 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 6/20 | 0.40 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA4 | P22748 | 3/20 | 0.40 |
| ▸ | CA6 | P23280 | 3/20 | 0.40 |
| ▸ | CA5A | P35218 | 3/20 | 0.40 |
| ▸ | CA7 | P43166 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL26654445 | 0.98 | LMNA (0.50) | LMNATSHRALDH1A1NT5ESMN1; SMN2 | |
| SCHEMBL2881344 | 0.98 | LMNA (0.50) | LMNATSHRALDH1A1NT5ESMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL23781867 | 0.98 | LMNA (0.50) | LMNATSHRALDH1A1NT5ESMN1; SMN2 | |
| SCHEMBL30968190 | 0.82 | LMNA (0.48) | LMNATSHRALDH1A1NT5ESMN1; SMN2 | |
| SCHEMBL314445 | 0.82 | LMNA (0.48) | LMNATSHRALDH1A1NT5ESMN1; SMN2 | |
| SCHEMBL17044644 | 0.80 | LMNA (0.46) | LMNATSHRALDH1A1NT5ESMN1; SMN2 | |
| SCHEMBL9619529 | 0.80 | LMNA (0.56) | LMNATSHRALDH1A1NT5ESMN1; SMN2 | |
| SCHEMBL1148233 | 0.80 | HTR6 (0.47) | LMNATSHRALDH1A1CES2CES1 | |
| SCHEMBL11583429 | 0.80 | LMNA (0.56) | LMNATSHRALDH1A1NT5ESMN1; SMN2 | |
| SCHEMBL150334 | 0.79 | LMNA (0.77) | LMNATSHRALDH1A1NT5ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1408047-B1 | PROCESS FOR PREPARATION OF ERYTHROMYCIN COMPOUNDS | UBE INDUSTRIES (JP) | 2005-10-26 | — | — | EP | claimed |
| US-6906039-B2 | Process for preparation of erythromycin compounds | UBE INDUSTRIES, LTD. (JP) | 2005-06-14 | — | — | US | claimed |
| US-20040192902-A1 | Process for preparing erythromycin compound | UBE INDUSTRIES, LTD. (JP) | 2004-09-30 | — | — | US | claimed |
| EP-1408047-A1 | PROCESS FOR PREPARATION OF ERYTHROMYCIN COMPOUNDS | Ube Industries, Ltd. (JP) | 2004-04-14 | — | — | EP | claimed |
| EP-0338004-B1 | POLYMER WITH BETAINE STRUCTURE, SOLUTION DIFFUSION MEMBRANE, PROCESS FOR THEIR MANUFACTURE AND USE | Deutsche Carbone AG (DE) | 1993-04-07 | — | — | EP | claimed |
| US-5164424-A | POLYMER HAVING A BETAINE STRUCTURE, SOLUTION DIFFUSION MEMBRANE, PROCESS FOR PRODUCING SAME AND USE THEREOF | DEUTSCHE CARBONE AG (DE) | 1992-11-17 | — | — | US | claimed |
| EP-0338004-A1 | POLYMER WITH BETAINE STRUCTURE, SOLUTION DIFFUSION MEMBRANE, PROCESS FOR THEIR MANUFACTURE AND USE. | GFT GES FUER TRENNTECHNIK (DE) | 1989-10-25 | — | — | EP | claimed |
| WO-1988004677-A1 | POLYMER WITH BETAINE STRUCTURE, SOLUTION DIFFUSION MEMBRANE, PROCESS FOR THEIR MANUFACTURE AND USE | GFT GESELLSCHAFT FÜR TRENNTECHNIK MBH (DE) | 1988-06-30 | — | — | WO | claimed |
| CN-119060221-A | Sulfonic acid functionalized polymer, ion exchange membrane and application thereof | 佛山绿动氢能科技有限公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-118420813-A | Sulfonated vinyl polymer, composite material, and preparation method and application thereof | 佛山绿动氢能科技有限公司 | 2024-08-02 | — | — | CN | disclosed |
| US-20230118459-A1 | ANTIVIRAL TREATMENT | ECOSYNTH NV (BE) | 2023-04-20 | — | — | US | disclosed |
| EP-4114376-A1 | ANTIVIRAL TREATMENT | Ecosynth (BE) | 2023-01-11 | — | — | EP | disclosed |
| US-10727516-B2 | Compound and polymer electrolyte membrane using same | LG CHEM, LTD. (KR) | 2020-07-28 | — | — | US | disclosed |
| EP-3235809-B1 | COMPOUND AND POLYMER ELECTROLYTE MEMBRANE USING SAME | LG CHEMICAL LTD (KR) | 2019-10-02 | — | — | EP | disclosed |
| EP-0338004-B1 | POLYMER WITH BETAINE STRUCTURE, SOLUTION DIFFUSION MEMBRANE, PROCESS FOR THEIR MANUFACTURE AND USE | Deutsche Carbone AG (DE) | 1993-04-07 | — | — | EP | disclosed |
| US-5164424-A | POLYMER HAVING A BETAINE STRUCTURE, SOLUTION DIFFUSION MEMBRANE, PROCESS FOR PRODUCING SAME AND USE THEREOF | DEUTSCHE CARBONE AG (DE) | 1992-11-17 | — | — | US | disclosed |
| EP-0338004-A1 | POLYMER WITH BETAINE STRUCTURE, SOLUTION DIFFUSION MEMBRANE, PROCESS FOR THEIR MANUFACTURE AND USE. | GFT GES FUER TRENNTECHNIK (DE) | 1989-10-25 | — | — | EP | disclosed |
| EP-0161482-B1 | FLUORINATED ANILINE DERIVATIVES AND THEIR USE | Roche Diagnostics GmbH (DE) | 1989-09-13 | — | — | EP | disclosed |
| WO-1988004677-A1 | POLYMER WITH BETAINE STRUCTURE, SOLUTION DIFFUSION MEMBRANE, PROCESS FOR THEIR MANUFACTURE AND USE | GFT GESELLSCHAFT FÜR TRENNTECHNIK MBH (DE) | 1988-06-30 | — | — | WO | disclosed |
| EP-0161482-A1 | Fluorinated aniline derivatives and their use | Roche Diagnostics GmbH (DE) | 1985-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230118459-A1 | ANTIVIRAL TREATMENT | MAVS, ACE, ACE2 | LMNA 1578/4885TSHR 4316/4885ALDH1A1 4719/4885 |
| US-20040192902-A1 | Process for preparing erythromycin compound | RIOX2, RPS6KA6, ERG28 | LMNA 2306/4885TSHR 2966/4885ALDH1A1 2882/4885 |
| US-10727516-B2 | Compound and polymer electrolyte membrane using same | TMEM109, PXMP4, VMA21 | LMNA 2972/4885TSHR 4620/4885ALDH1A1 2080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.